NonilexIn total, the 10 #drugs selected for negotiation accounted for $3.4 billion in #out_of_pocket #costs for an estimated 9 million #Medicare enrollees in 2022. These drugs are used to treat #HeartFailure, #diabetes, #arthritis, #cancers, #BloodClots, & other conditions.
Over the next 4 years, Medicare will negotiate prices for up to 60 drugs covered under #MedicarePartD & #MedicarePartB, & up to an additional 20 drugs every year after that.